ArticleJournal of clinical and experimental hepatology

Real-world Prevalence of Hepatitis B Reactivation in Patients With Resolved Hepatitis B Receiving Rituximab and Non-rituximab-based Immunosuppressive Therapy Without Chemoprophylaxis.

Valerie Yeap et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.